New Drugs for Rheumatoid Arthritis: What's in the Pipeline
Links shared publicly online about this topic.
- 994total visits
New Drugs for Rheumatoid Arthritis: What's in the Pipeline
View full resource at webmd.com
Tags: Arthritis, Rheumatoid Arthritis, Drug
Most Recently Shared on July 26, 2010 at 6:13 pm By:
New Drugs for Rheumatoid Arthritis: What's in the Pipeline: The latest on research and development about oral biol... http://bit.ly/aVhjZO
Why Pfizer’s Biggest Experimental Drug Got A Name Change - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “Earlier this week Pfizer released a neat-o interactive version of its pipeline of experimental drugs, including updates on which have moved into new clinical trials. One surprise: the generic name for the company's new JAK3 inhibitor for rheumatoid arthritis had changed. Once known as tasocitinib, it will henceforth be known as [...]” View full resource at blogs.forbes.com
Most Recently Shared on March 3, 2011 at 5:31 am By:
Why Pfizer's Biggest Experimental Drug Got A Name Change: Why one of Pfizer's experimental medicines had i... http://bit.ly/fCvDg8 #drug
Conquering Arthritis: New Rheumatoid Arthritis Medications: The Life Threatening FDA Drug Approval Process
rheumatoidarthritistreatmentarthritis.blogspot.com — “Conquering Arthritis: New Rheumatoid Arthritis Medications: The Life Threatening FDA Drug Approval Process” View full resource at rheumatoidarthritistreatmentarthritis.blogspot.com
Most Recently Shared on February 10, 2011 at 5:25 am By:
New Article: New Rheumatoid Arthritis Medications: The Life Threatening FDA Drug Approval Process: http://fd.ag/2PTY What do you think?
Medical News: ACR: New RA Drug Tops Meeting Agenda - in Meeting Coverage, ACR from MedPage Today
medpagetoday.com — “ATLANTA -- Rheumatologists will get a much-anticipated look at phase III results for a novel rheumatoid arthritis drug with blockbuster potential during what promises to be a busy week at the American” View full resource at medpagetoday.com
Most Recently Shared on November 5, 2010 at 9:07 pm By:
ACR: New RA Drug Tops Meeting Agenda: ATLANTA (MedPage Today) -- Rheumatologists will get a much-anticipated loo... http://bit.ly/bzKW42
Advertisement

